1 | mainly | 9,191 |
2 | primarily | 5,228 |
3 | solely | 933 |
4 | principally | 427 |
5 | chiefly | 153 |
6 | excepted | 12 |
7 | majorly | 11 |
8 | 'awa | 5 |
9 | interconnect | 4 |
10 | 2,320 | 2 |
11 | co-compound | 2 |
12 | prolifically | 2 |
13 | remotivation | 2 |
14 | 1-aryl-2-hydrazonoimidazolidine | 1 |
15 | 187/337 | 1 |
16 | 1b-1v | 1 |
17 | 534,267 | 1 |
18 | abandonments | 1 |
19 | axifera | 1 |
20 | cox-independently | 1 |
21 | disease-education | 1 |
22 | goffers | 1 |
23 | halberstadt-freud | 1 |
24 | headache-diary | 1 |
25 | insulin-independently | 1 |
26 | mg-y-zr | 1 |
27 | mol-c | 1 |
28 | monophyletically | 1 |
29 | non-dsm | 1 |
30 | non-office | 1 |
31 | non-questionnaire | 1 |
32 | non-xanthine | 1 |
33 | ofsynthesis | 1 |
34 | overtoasted | 1 |
35 | pseudoperitonitis | 1 |
36 | sigmae | 1 |
37 | signal-histogram | 1 |
38 | tac/cya | 1 |
39 | tochronic | 1 |
40 | unquestioningly | 1 |
41 | vectorily | 1 |
42 | β-1,6-specificity | 1 |
1 | 'awa | 5 |
2 | 1-aryl-2-hydrazonoimidazolidine | 1 |
3 | 187/337 | 1 |
4 | 1b-1v | 1 |
5 | 2,320 | 2 |
6 | 534,267 | 1 |
7 | abandonments | 1 |
8 | axifera | 1 |
9 | chiefly | 153 |
10 | co-compound | 2 |
11 | cox-independently | 1 |
12 | disease-education | 1 |
13 | excepted | 12 |
14 | goffers | 1 |
15 | halberstadt-freud | 1 |
16 | headache-diary | 1 |
17 | insulin-independently | 1 |
18 | interconnect | 4 |
19 | mainly | 9,191 |
20 | majorly | 11 |
21 | mg-y-zr | 1 |
22 | mol-c | 1 |
23 | monophyletically | 1 |
24 | non-dsm | 1 |
25 | non-office | 1 |
26 | non-questionnaire | 1 |
27 | non-xanthine | 1 |
28 | ofsynthesis | 1 |
29 | overtoasted | 1 |
30 | primarily | 5,228 |
31 | principally | 427 |
32 | prolifically | 2 |
33 | pseudoperitonitis | 1 |
34 | remotivation | 2 |
35 | sigmae | 1 |
36 | signal-histogram | 1 |
37 | solely | 933 |
38 | tac/cya | 1 |
39 | tochronic | 1 |
40 | unquestioningly | 1 |
41 | vectorily | 1 |
42 | β-1,6-specificity | 1 |
1 | 2,320 | 2 |
2 | 187/337 | 1 |
3 | 534,267 | 1 |
4 | axifera | 1 |
5 | 'awa | 5 |
6 | tac/cya | 1 |
7 | mol-c | 1 |
8 | tochronic | 1 |
9 | excepted | 12 |
10 | overtoasted | 1 |
11 | co-compound | 2 |
12 | halberstadt-freud | 1 |
13 | sigmae | 1 |
14 | non-office | 1 |
15 | 1-aryl-2-hydrazonoimidazolidine | 1 |
16 | non-xanthine | 1 |
17 | non-questionnaire | 1 |
18 | signal-histogram | 1 |
19 | non-dsm | 1 |
20 | disease-education | 1 |
21 | remotivation | 2 |
22 | mg-y-zr | 1 |
23 | ofsynthesis | 1 |
24 | pseudoperitonitis | 1 |
25 | goffers | 1 |
26 | abandonments | 1 |
27 | interconnect | 4 |
28 | 1b-1v | 1 |
29 | solely | 933 |
30 | chiefly | 153 |
31 | unquestioningly | 1 |
32 | primarily | 5,228 |
33 | vectorily | 1 |
34 | prolifically | 2 |
35 | monophyletically | 1 |
36 | principally | 427 |
37 | mainly | 9,191 |
38 | majorly | 11 |
39 | insulin-independently | 1 |
40 | cox-independently | 1 |
41 | headache-diary | 1 |
42 | β-1,6-specificity | 1 |